Latest Pharmaceutical Insights
Shutterstock
Innovation, Alliances, and the Environment: 2024 Priorities for Drug Manufacturers
Adaptability, global collaboration, supply chain innovation and mRNA technologies were just some of the key trends in 2023. Rephine’s Dr. Eduard Cayón expects these themes to continue to develop and accelerate in 2024. Read more
1 Dec 2023
Shutterstock
Simplifying CGT: A Necessary Precursor to Integrating AI and Automation
Josh Ludwig, Global Commercial Director, ScaleReady explores the necessity of simplifying cell and gene therapy in order to successfully integrate artificial intelligence and automation technologies in our latest EPM insight. Read more
1 Dec 2023
Shutterstock
Pacesetting Pharma Firms Drive Innovation with Systemic HR Practices and Talent Intelligence
Jordan Schmitting of The Josh Bersin Company offers practical tips on how pharma firms can address this challenge by rethinking their approach to future-proofing talent and product pipelines. Read more
30 Nov 2023
Shutterstock
Supply Chain Resiliency: A Lifeline in the Face of Drug Shortages
Bindiya Vakil, CEO and founder of Resilinc, is an award-winning expert in supply chain risk management who explores supply chain resiliency: a lifeline in the face of drug shortages in our latest EPM insights. Read more
30 Nov 2023
Shutterstock
Pharma manufacturers at Risk of Increased Liability Exposures
Samantha Silver and Charlie Whitchurch from global law firm Kennedys explore some of the key legislative developments that will impact manufacturers operating in the life sciences sector as they enter 2024 for EPM. Read more
28 Nov 2023
Shutterstock
Leveraging Artificial Intelligence for Enhanced Inventory Management of Single-Use Solutions
Timothy Korwan, Director of Technical Applications; Alex Joyner, Digital Lab Product Manager; and Sarah Ann Landry, Operations Manager, Fluid Handling Solutions, at Avantor discuss leveraging AI for inventory management of single-use solutions. Read more
28 Nov 2023
Powering digital transformation in drug discovery
Shafique Virani, chief corporate development officer and interim chief medical officer, Recursion, delves into digital transformation within drug discovery and the power of AI-enabled platforms in the future of therapeutics. Read more
7 Dec 2022
The regulatory shift: Laboratory services post-Brexit
Chris Allen, CEO of UK-based analytical testing and scientific consultancy provider Broughton, explains the challenges — and opportunities — that Brexit holds for laboratory services. Read more
12 Oct 2022
Perspective on pharma: Post-pandemic lessons
Noel Maestre, PE, vice president of Life Sciences, and David Estape, technology manager Biotechnology at CRB discuss how virus response rewrote the playbook for vaccine response, but even more change is necessary to deal with emerging threats. Read more
12 May 2022
How pharmaceutical manufacturers can benefit from moving to cloud today
For pharmaceuticals manufacturers, progressing digitalisation and moving to the cloud has been notoriously slow, and misperceptions of what moving to the cloud entails have been a significant factor in this lack of adoption. Read more
12 May 2022
Driving drug discovery with micromotors
Dave Walsha, sales manager at precision drive system supplier, Electrical Mechanical Systems (EMS), explores how micromotors are helping drug discovery. Read more
25 Apr 2022
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Cancer immunotherapy: the best is yet to come
Justin Wilson, partner and attorney at Withers & Rodgers, discusses his opinion on the promising innovations in the microbiome and the role of IP in supporting the discovery of new drugs and treatments. Read more
13 Apr 2022
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
White Papers
Air flow smoke pattern testing: a new challenge in a subjective test in Annex 1 EU GMP
New definition in Annex 1 EU GMP in force since August 25, 2023, one year after publication in Eudralex Volume 4, except for point 8.123, which will be in 2025 Read more
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15